用CRISPR-Cas9进行哺乳动物细胞抗生素耐药性基因快速编辑的协议
Petia Adarska1, Eleanor Fox1, Joshua Heyza2
1Freie Universität Berlin, Institute of Chemistry and Biochemistry, Thielallee 63, 14195 Berlin, Germany.
STAR protocols
|August 6, 2025
概括
这项研究引入了一种快速的CRISPR-Cas9基因编辑协议 (FAB-CRISPR),用于高效的蛋白质标记. FAB-CRISPR利用抗生素耐药性快速选择编辑的细胞,改善蛋白质功能研究.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 克里斯普尔-Cas9基因编辑允许在本地环境中标记蛋白质.
- 低同质定向修复 (HDR) 的效率限制了当前的CRISPR-Cas9标记方法.
研究的目的:
- 通过使用CRISPR-Cas9.9进行N/C端蛋白标记的简化协议.
- 为了提高蛋白质研究基因编辑的效率.
主要方法:
- 开发了一个基于抗生素耐药性的快速CRISPR-Cas9 (FAB-CRISPR) 协议.
- 利用抗生素耐药性磁带进行基因编辑细胞的选择和丰富.
- 详细指南RNA和HDR供体等离子体克隆,转化为HeLa细胞,以及验证方法.
主要成果:
- FAB-CRISPR协议使基因编辑细胞的快速选择和丰富成为可能.
- 简化了蛋白质在其本源细胞环境中的N / C-终端标记.
- 在HeLa细胞中成功应用.
结论:
- FAB-CRISPR提供了一种有效的CRISPR-Cas9介导蛋白质标记方法.
- 该协议通过抗生素耐药性选择提高基因编辑效率.
- 方便在体内对蛋白质功能的研究.
相关概念视频
CRISPR/Cas9 Genome Editing
227
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
227
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K


